SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-16-017384
Filing Date
2016-08-11
Accepted
2016-08-11 17:01:47
Documents
56
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1601924_10q.htm 10-Q 570856
2 EXHIBIT 3.1 t1601924_ex3-1.htm EX-3.1 25755
3 EXHIBIT 31.1 t1601924_ex31-1.htm EX-31.1 9959
4 EXHIBIT 31.2 t1601924_ex31-2.htm EX-31.2 9987
5 EXHIBIT 32.1 t1601924_ex32-1.htm EX-32.1 3635
6 EXHIBIT 32.2 t1601924_ex32-2.htm EX-32.2 3965
  Complete submission text file 0001571049-16-017384.txt   2931065

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE cycc-20160630.xml EX-101.INS 433412
8 XBRL SCHEMA FILE cycc-20160630.xsd EX-101.SCH 32873
9 XBRL CALCULATION FILE cycc-20160630_cal.xml EX-101.CAL 30370
10 XBRL DEFINITION FILE cycc-20160630_def.xml EX-101.DEF 116700
11 XBRL LABEL FILE cycc-20160630_lab.xml EX-101.LAB 304765
12 XBRL PRESENTATION FILE cycc-20160630_pre.xml EX-101.PRE 213614
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 161825330
SIC: 2834 Pharmaceutical Preparations